Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Concurrent Chemoradiation Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00271323
What this trial is testing

Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients

Who this might be right for
Non-Small-Cell Lung Carcinoma
Sanofi 14
Large-scale testing (Phase 3)Active Not RecruitingNCT04092283
What this trial is testing

Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+3 more
National Cancer Institute (NCI) 660
Testing effectiveness (Phase 2)Looking for participantsNCT07232654
What this trial is testing

Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC

Who this might be right for
LOCALLY ADVANCED CERVICAL CANCERS
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Testing effectiveness (Phase 2)UnknownNCT06422858
What this trial is testing

Sequential Tegafur-gimeracil-oteracil Potassium Capsule (s-1) and Serplulimab Following Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Inoperable Esophageal Squamous Cell Carcinoma
Zhejiang Cancer Hospital 37
Large-scale testing (Phase 3)Study completedNCT00227747
What this trial is testing

Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer

Who this might be right for
Colorectal Cancer
UNICANCER 598
Early research (Phase 1)Study completedNCT00003263
What this trial is testing

Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Mesothelioma
Fox Chase Cancer Center 6
Testing effectiveness (Phase 2)UnknownNCT03557112
What this trial is testing

By Comparing TPF Induction Chemotherapy Combined With Nimotuzumab Concurrent Radiotherapy and Cisplatin Concurrent Radio-chemotherapy for Locally Advanced NPC

Who this might be right for
Nasopharyngeal Carcinoma
Guiyang Medical University 180
Testing effectiveness (Phase 2)Study completedNCT05635734
What this trial is testing

Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Cantex Pharmaceuticals 33
Large-scale testing (Phase 3)Study completedNCT00379262
What this trial is testing

Therapeutic Gain by Induction-concurrent Chemoradiotherapy and/or Accelerated Fractionation for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Hong Kong Nasopharyngeal Cancer Study Group Limited 803
Large-scale testing (Phase 3)Study completedNCT02573324
What this trial is testing

ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification

Who this might be right for
GlioblastomaGliosarcoma
AbbVie 691
Testing effectiveness (Phase 2)UnknownNCT03701451
What this trial is testing

Demethylated Drug in the Treatment of Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Wei Jiang 30
Testing effectiveness (Phase 2)UnknownNCT01938105
What this trial is testing

Preoperative Chemoradiotherapy Combined With Nimotuzumab for Cervical Cancer

Who this might be right for
Locally Advanced Cervical Cancer
People's Hospital of Guangxi Zhuang Autonomous Region 40
Not applicableWithdrawnNCT01314677
What this trial is testing

Fludeoxyglucose F 18 PET/CT Scans in Predicting Therapy Response in Patients With Stage IIIA Non-Small Cell Lung Cancer Undergoing Chemoradiation

Who this might be right for
Stage IIIA Non-small Cell Lung Cancer
City of Hope Medical Center
Large-scale testing (Phase 3)UnknownNCT03908372
What this trial is testing

Optimized Treatment Strategies for Early and Medium Stage Nasopharyngeal Carcinoma

Who this might be right for
Stage II, IIINasopharyngeal Squamous Cell CarcinomaInduction Chemotheray+2 more
Chinese Academy of Medical Sciences 120
Testing effectiveness (Phase 2)UnknownNCT03368131
What this trial is testing

Concurrent Neoadjuvant Chemoradiotherapy Plus Trastuzumab in the Treatment of Siewert II ，III of Human Epidermal Growth Factor Receptor-2(HER-2) Positive Gastroesophageal Junction Adenocarcinoma： A Randomized, Controlled Clinical Study

Who this might be right for
Gastroesophageal Junction Adenocarcinoma
Hebei Medical University 48
Testing effectiveness (Phase 2)UnknownNCT04121975
What this trial is testing

CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Zhejiang Cancer Hospital 82
Testing effectiveness (Phase 2)UnknownNCT02080234
What this trial is testing

Combine GELOX With Concurrent Radiation Therapy for Patients With Stage IE/IIE ENKTL

Who this might be right for
Lymphoma, Extranodal NK-T-Cell
Sun Yat-sen University 40